This study evaluates the in vitro inhibition of angiotensin-converting enzyme (ACE) and 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA) by Pleurotus pulmonarius extracts. The protective effect on the endothelial membrane against oxidative stress through the protection of nitric oxide bioavailability, as well as inhibition of endocan expression, was evaluated using human aortic endothelial cells (HAECs). Crude cold aqueous extract exhibited the most potent inhibitory activities against ACE and HMG-CoA reductase, with 61.79% and 44.30% inhibition, respectively. It also protected the bioavailability of NO released by HAECs, with 84.88% cell viability. The crude hot water extract was the most potent in inhibiting endocan expression, with 18.61% inhibition.
I. INTRODUCTION
Atherosclerosis is the most prevalent life-threatening disease and cause of death worldwide.
1 It leads to coronary heart disease and stroke.
2 Nitric oxide (NO) is known to have antiatherogenic properties; it causes vasodilation and protects the endothelial membrane. The overexpression of reactive oxygen species such as hydrogen peroxide (H 2 O 2 ) may contribute to reductions of NO bioactivity and increases the formation of peroxynitrite. Thus, H 2 O 2 and peroxynitrite subsequently lead to endothelial dysfunction. 1 Endothelial higher in patients diagnosed with hypertension than in normal participants. 3 positively correlate with carotid intima media thickness and high-sensitivity C-reactive protein. Angiotensin-converting enzyme (ACE) plays an important role in blood pressure homeostasis. ACE is involved in the conversion of angiotensin I to angiotensin II by cleaving the C-terminal dipeptide His 9 -Leu 10 from angiotensin I. 4 Overexpression of angiotensin II causes blood vessels to constrict quickly, resulting in hypertension. Angiotensin II also prompts the activation of several pathways that initiate atherogenesis the AT 1 receptor in the vasculature. 5 The stimulation of AT 1 dysfunction, and eventually leads to the formation of atherosclerotic plaque.
5,6
3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase is a rate-limiting enzyme in the metabolism of endogenous cholesterol. It is responsible for catalyzing the conversion of HMG-CoA to mevalonic acid in the mevalonate pathway. 7 High cholesterol, or hypercholesterolemia, induces dis--phages. 8 In addition, elevated cholesterol induces the formation of angiotensin II, which then leads to endothelial dysfunction and atherosclerosis. 5 Thus, compounds that can reduce these risk factors could prevent and/or treat atherosclerosis. To date, the demand for natural sources as alternatives to commercial 9 China is the biggest producer of edible mushrooms, and Pleurotus species are produced most.
10 Pleurotus cholesterol-lowering, antihypertensive, and anti-platelet aggregation effects.
9,11,12
The gray oyster medicinal mushroom, P. pulmonarius is the most commonly cultivated and consumed mushroom throughout the world, because it is easily cultivated under various conditions. 13 Numerous studies have been published on its medicinal properties.
11, 12, 14, 15 The objective of this study was to evaluate the in vitro antiatherogenic capacities of extracts from P. pulmonarius based on inhibition of ACE activity, inhibition of HMG-CoA reductase activity, and the protective effect of extracts on the endothelial membrane against oxidative stress. The nutraceutical and
II. MATERIALS AND METHODS

A. Mushroom Material
P. pulmonarius fruiting bodies were obtained from a mushroom farm (Vita Agrotech Sdn. Bhd., Selangor, of internal transcribed spacer regions. The culture was deposited at the Mycological Laboratory of the Mushroom Research Centre, University of Malaya (registration no. KUM61119). A voucher of the specimen was deposited at the University of Malaya Herbarium (registration no. KLU-M1234). The mushrooms were immediately washed with distilled water to remove dirt.
B. Preparation of the Methanol-Dichloromethane Extract and Liquid-Liquid Solvent Fractions
were prepared as previously described. 16 evaporated under reduced pressure extract was then redissolved in 90% aqueous methanol and partitioned 3 times with 100 mL hexane. The HF was separated and rotary evaporated to dryness. The residual aqueous methanol was evaporated under pressure to produce a semisolid mass, which was then dissolved in 200 mL distilled water. After successive partitioning 3 times with 100 mL dichloromethane or 100 mL ethyl acetate, the resulting yield respective extracts.
C. Preparation of the Cold Aqueous and Crude Hot Water Extracts
ies soaked in distilled water at a ratio of 1:10 (w/v) were continuously agitated overnight at 4°C and then was collected and dried in an oven at 60°C for 12 hours. This residue was then boiled in water at a ratio of
D. ACE Inhibitory Activity
Ability to inhibit hypertension through the inhibition of ACE was determined using an ACE inhibitory -lated based on the percentage inhibition, calculated using the following equation:
Inhibition (%) =
A blank 1 A sample × 100
where A is the absorbance.
E. HMG-CoA Reductase Inhibitory Activity
Inhibition of cholesterol synthesis was evaluated based on HMG-CoA reductase inhibitory activity using an HMG-CoA reductase assay kit from Sigma-Aldrich (St. Louis, MO). The activity of the product was expressed as the percentage inhibition according to the following equation:
Inhibition (%) = A(Enzyme activity) A treated × 100
A(Enzyme actvity)
F. Cell Culture
Human aortic endothelial cells (HAECs) were purchased from Lonza and maintained in EBM-2 complete growth factor-B, 0.5 mL vascular endothelial growth factor, 0.5 mL R3 insulin-like growth factor 1, 0.5 mL ascorbic acid, 0.5 mL human epidermal growth factor, 0.5 mL GA-1000, 0.5 mL heparin, and 10.0 mL fetal bovine serum growth factor. The cells were seeded (2500-5000 cells/cm 2 2 . The growth medium was changed the day after seeding and every 2 days thereafter.
G. Cell Preparation and Treatment
were enumerated using a hemocytometer. The cells were then seeded into 96-well plates at a density of 10,000 cells/well. The HAECs were grown in the 96-well plate for 24 hours before they were treated with hours, the cells were exposed to H 2 O 2 proceeding with further assays.
H. Nitric Oxide
HAECs were seeded at a density of 1 × 10 4 cells/well in a 96-well plate, and the NO level was determined 15 0.1% N-[1-211 naphthyl] ethylenediamine in 2.5% H 3 4 ; Sigma-Aldrich) was added. The NO level was measured at 540 nm after 10 minutes of incubation with the Griess reagent. The result was presented as the percentage NO relative to the untreated cells, which comprised the negative control group.
I. Endocan (ESM-1)
The endocan (ESM-1) level was determined using a human endocan/ESM-1 enzyme-linked immunosorbent assay kit (Lunginnov).
III. RESULTS AND DISCUSSION
A. In Vitro Antihypertensive Activity through ACE Inhibition
The ACE inhibitory assay kit uses an enzyme-based assay in which 3-hydroxybutyryl (3HB)-Gly-GlyGly is used as a substrate for ACE. The amount of fragmented 3HB cleaved from 3HB-Gly-Gly-Gly was determined, and the ACE inhibitory activity was calculated as the percentage inhibition. Captopril (Sigma; 1 × 10 used. According to Fig. 1 , the CA extract showed the highest percentage inhibition, at 61.79%, followed
FIG. 1:
Angiotensin-converting enzyme inhibitory activity of the captopril and Pleurotus pulmonarius extracts at 1 × 10 P < 0.05. CA, crude aquedichloromethane water fraction. ACE inhibitors normally come from peptides, such as those with the amino acid sequences Val-Ile-GluGrifola frondosa Tricholoma giganteum. 17,18 Based on previous work, however, ACE inhibitory activity and protein content correlate weakly.
14 Hence, presumably small metabolites other than protein are able to bind to the active site of ACE and thereby inhibit its activity.
B. Inhibition of Cholesterol Synthesis through the Inhibition of HMG-CoA
Reductase Activity oxidase. Therefore, HMG-CoA reductase activity can be measured based on the decrease in absorbance at control for the HMG-CoA reductase inhibitory activity assay, and the extract concentration was 10 mg/mL. Figure 2 shows that the CA extract (10 mg/mL) is most potent, inhibiting 44.3% of HMG-CoA reductase activity compared with lovastatin, which exhibited 48.10% inhibition at 1 mg/mL. This result is in accordance with work by Gil-Ramirez et al. 19 on the inhibition of HMG-CoA reductase activity by P. ostreatus extracts prepared using different extraction methods. They showed that an aqueous extract had higher HMG-CoA reductase inhibitory activity than extracts obtained with other solvents. In that study, ergosta-5,7-dienol (an 
IV. CONCLUSIONS
This study revealed that the CA extract from P. pulmonarius, consisting of ergothioneine, methyl ellagic acid, and phenolics, exhibited the most potent ACE inhibitory activity, HMG-CoA reductase inhibitory P. pulmonarius contains
Further animal and clinical studies need to be done to investigate the effect of the potent P. pulmonarius
